You are here: Industry Insights > Health Canada

News List

EMA and Health Canada to make COVID-19 vaccine data open access europeanpharmaceuticalreview
March 08, 2021
Starting with the publication of clinical data used to support the authorisations of the Moderna COVID-19 vaccine, EMA and Health Canada said they will continue the open access approach for all COVID-19 vaccines.
British Columbia rejects Health Canada-approved antibody drug for Covid-19 pharmaceutical-technology
January 12, 2021
British Columbia (BC) has rejected a Health Canada-approved antibody drug, bamlanivimab, for treating Covid-19 citing very limited safety data.
Moderna’s Covid-19 vaccine obtains Health Canada authorisation pharmaceutical-technology
December 25, 2020
Moderna has received authorisation for its Covid-19 vaccine from Health Canada for the immunisation of individuals aged 18 years and above.
Dr. Reddy’s seeks approval from Health Canada for Covid-19 treatment pharmaceutical-technology
December 24, 2020
Dr. Reddy’s Canada has filed an application with Health Canada on behalf of the consortium for Reeqonus (favipiravir) tablets for acute treatment of mild to moderate Covid-19 in adult patients.
Therapix Biosciences announces Canadian Product License Issuance for CannAmide biospectrumasia
August 01, 2019
This license is issued by Health Canada under the authority of the Natural Health Products Regulations
Health Canada approves Biocon and Mylan’s Ogivri for cancer treatment expressbpd
May 30, 2019
Ogivri, used for the treatment of HER2-Positive breast and gastric cancers, is the first trastuzumab biosimilar approved in Canada and the second biosimilar from Biocon and Mylan’s joint portfolio approved in the market
Health Canada approves new drug to treat metastatic breast cancer through international and domestic joint reviews firstwordpharma
April 10, 2019
OTTAWA, April 9, 2019 /CNW/ - Canadians want improved access to the most recent and innovative treatment options for themselves and their families.
Health Canada Approves CIMZIA (certolizumab pegol) for Moderate-to-Severe Psoriasis firstwordpharma
March 26, 2019
UCB Canada Inc. announced today that Health Canada has approved a new indication for……
Health Canada Approves Otsuka and Lundbeck's REXULTI (brexpiprazole) as Adjunctive Treatment of Major Depressive Disorder firstwordpharma
February 23, 2019
"Brexpiprazole, is a new option for patients with MDD who require augmentation therapy. Its unique mechanism of action and potential benefits will be a new source of optimism for patients suffering from Depression" said Dr. Diane McIntosh.
Health Canada Approves RITUXAN Subcutaneous Formulation for Canadians with Chronic Lymphocytic Leukemia firstwordpharma
March 23, 2018
Hoffmann-La Roche Limited announced today that Health Canada has approved RITUXAN® subcutaneous for the treatment of patients with previously untreated or previously treated B-cell chronic lymphocytic leukemia, Binet Stage B or C, in combination with flu

Previous page 1 2 3 Next page